Telomir Pharmaceuticals, Inc. (TELO) earnings
Quarterly results of Telomir Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Telomir Pharmaceuticals, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Telomir Pharmaceuticals, Inc. reported revenue of - and a net loss of $1.7M.
Diluted earnings per share were -$0.79.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$1.7M | -$0.79 |
| Q1 FY2026 | - | - | -$990.9K | -$0.03 |
| Q4 FY2025 | - | - | -$2.1M | - |
| Q3 FY2025 | - | - | -$1.1M | -$0.03 |
| Q2 FY2025 | - | - | -$5.1M | -$0.17 |
| Q1 FY2025 | - | - | -$2.2M | -$0.07 |
| Q4 FY2024 | - | - | -$2.9M | - |
| Q3 FY2024 | - | - | -$6M | -$0.20 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Telomir Pharmaceuticals, Inc.'s next earnings date?
Telomir Pharmaceuticals, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Get an email when TELO reports
Follow TELO and we email you its next results the day they are filed, with the numbers explained.